Vidyya Medical News Service
Volume 6 Issue 195 Published - 14:00 UTC 08:00 EST 13-Jul-2004 Next Update - 14:00 UTC 08:00 EST 14-Jul-2004
little clear gif used for spacer

Updated guidelines support lowering of cholesterol in those at risk for heart attack, stroke
The National Cholesterol Education Program (NCEP) has updated its guidelines for treatment of blood cholesterol, suggesting that people at risk for heart attack and stroke would benefit from more intensive cholesterol-lowering therapies.  more

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Scientists point to Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Tests by researchers have found signs of a virus called MMTV in tissue taken from women with the disease. more

Update on cholesterol guidelines: more-intensive treatment options for higher risk patients
A 2004 update to the National Cholesterol Education Program's (NCEP) clinical practice guidelines on cholesterol management advises physicians to consider new, more intensive treatment options for people at high and moderately high risk for a heart attack. These options include setting lower treatment goals for LDL ("bad") cholesterol and initiating cholesterol-lowering drug therapy at lower LDL thresholds.  more


Combination of gene therapy and gene silencing prevents neurodegenerative disease
People with an irregular heart rhythm are more likely to have sleep apnea than other cardiology patients.  more

Appetite-stimulating hormone levels decrease after gastric bypass surgery
Severely obese patients who undergo gastric bypass surgery show significant early declines in levels of a hormone that stimulates the appetite. This may possibly explain, in part, the loss of hunger sensation and rapid weight loss observed following gastric bypass, according to an article in the July issue of The Archives of Surgery, one of the JAMA/Archives journals.  more

Beta-blocker drugs well tolerated for heart failure patients
Beta-blocker therapy in patients with heart failure is well tolerated and associated with fewer overall withdrawals and less heart failure deterioration than placebo.  more

Medication can help diabetics lose weight, but long-term effects uncertain
An antidepressant drug and two medications for weight loss can help patients with diabetes achieve statistically significant weight loss over 26 to 52 weeks. But the magnitude of weight loss was modest, and the long-term health benefits and safety remain unclear. more

little clear gif used for a space